Market Cap 11.55M
Revenue (ttm) 19.10M
Net Income (ttm) -46.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -245.55%
Debt to Equity Ratio 1.82
Volume 17,400
Avg Vol 349,792
Day's Range N/A - N/A
Shares Out 9.09M
Stochastic %K 21%
Beta 1.42
Analysts Strong Sell
Price Target $3.00

Company Profile

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the adva...

Industry: Packaging & Containers
Sector: Consumer Cyclical
Phone: 585 325 3610
Address:
275 Wiregrass Parkway, West Henrietta, United States
PSM_EmpowerTrading
PSM_EmpowerTrading Oct. 24 at 7:25 PM
⏳️ Potential swing ideas 💡 ✅️ $DSS company focuses on health information software development and systems integration, providing services and solutions used daily by thousands of clinicians and administration staff nationwide in the public and private sectors, ✅️ $CSAI announced contract to secure luxury high-rise in HOuston, announced partnerships with National Property management firm to enhance security with AI Surveillance Solutions, also, announced partnership with Crypto-mining company to cut AI operation costs using renewable energy data center in Montana, won "Project Management Solution of the year", upcoming catalyst: present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8–10, 2025, company specializing in cloud-based video surveillance, storage, analytics and monitoring solutions, offering leverage AI and computer vision to enhance security systems, Analyst price target $6, buy rating, does have mixed shelf, be mindful on next spike
1 · Reply
johannn
johannn Oct. 23 at 9:30 AM
$PRPH $DSS $AEI $IBO Aha, I see that Prophase is happy to adopt my findings and has deleted all their previous presentations because they contained quite a few inaccurate things. https://ir.prophaselabs.com/presentations
1 · Reply
johannn
johannn Oct. 23 at 6:29 AM
$PRPH $DSS $IBO https://ap.lc/pYYOb So, health insurance companies are paying $50 to $100 to those performing COVID tests, but there were "companies" charging much more for COVID tests. So, the companies that quickly made heavy investments to jump into the testing business will be running at a heavy loss. And I'm not even talking about the who tried to invoice for unperformed tests. If Ted already paid $2.5 million to take over the lease of an old testing labo. Now let's correct the esophageal cancer figures: they're only 22,070, not 22 million. So, 22,070 in the entire year 2025 (seer.cancer.gov/statfacts/h...) will have developed esophageal cancer. Whether those SUSPECTED 20 or 7 million esophageal tests were really necessary or were actually performed, I suspect someone somewhere made a mistake, and that error was copied without question. So, Ted's future profit figures for ESophageal cancer can also be consigned to the realm of fantasy. https://ap.lc/gaVJg https://ap.lc/ZTZSs
1 · Reply
Greenblacks
Greenblacks Oct. 22 at 8:24 PM
$DSS like this setup
0 · Reply
johannn
johannn Oct. 22 at 2:34 PM
$PRPH $DSS $IBO $AEI I knew it... And here again, the hyped medical journal is simply part of Elsevier publishing and isn't free, but Prophase had to pay to be included. There will be a pre-screening process to ensure it's not completely full of nonsense, but being included doesn't mean it's ready to be carved in stone/immortalized for eternity. https://www.cghjournal.org/open-access-information https://www.elsevier.com/about/policies-and-standards/pricing 🕵️‍♀️🕵️‍♀️🥷🥷👨‍🦯👨‍🦯 So, Prophase no longer has a lab/headquarters, is practically broke, and those $50 million in fantasy dollars won't amount to anything either. So, I wonder which news was actually good news if the good news was actually bought news. https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/
0 · Reply
johannn
johannn Oct. 22 at 12:28 PM
$PRPH $DSS $IBO $AEI Now, comparing the two press releases—the first one about the acquisition and the latter from today—we see the lies and discrepancies. Acquisition link: https://ir.prophaselabs.com/news-events/press-releases/detail/169/prophase-labs-acquires-rights-to-novel-esophageal-cancer Today's link: https://www.globenewswire.com/news-release/2025/10/22/3170995/0/en/ProPhase-Labs-Announces-Study-Validating-BE-Smart-Esophageal-Cancer-Test-Accepted-by-Journal-of-Clinical-Gastroenterology-and-Hepatology.html Unfortunately, Prophase will no longer have a headquarters/laboratory to perform the test in a few years. https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/ 🕵️‍♀️🕵️‍♀️🥷🥷👨‍🦯👨‍🦯
1 · Reply
johannn
johannn Oct. 22 at 12:04 PM
$PRPH $DSS $IBO https://www.stocktitan.net/news/PRPH/pro-phase-labs-announces-study-validating-be-smart-esophageal-cancer-02xgn6pt5zzp.html
0 · Reply
johannn
johannn Oct. 22 at 11:52 AM
$PRPH $DSS $IBO Laboratory/office space for rent including equipment.🕵️‍♀️🕵️‍♀️🥷🥷👨‍🦯👨‍🦯 https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/
0 · Reply
johannn
johannn Oct. 22 at 11:34 AM
$PRPH $DSS $AEI $HWH $IBO The empty box company no longer has a real office but a virtual office box virtual address is ProPhase Labs, Inc. 626 RXR Plaza, 6th Floor. Uniondale, NY 11556. (516) 989-0763. (Name, address, including zip code. The actual office used to be located at ProPhase Labs' corporate office, 711 Stewart Ave Ste 200, Garden City, New York, 11530. But now you can rent it... This office/medical space is available for lease. This property is within close proximity to Meadowbrook Parkway. https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/ So you put your money in an empty box and then set it on fire. That's how you conduct research. 🕵️‍♂️🕵️‍♂️🥷🥷🕵️‍♀️🕵️‍♀️
0 · Reply
johannn
johannn Oct. 21 at 8:34 PM
$IBO $DSS That's strange. Sweet Sense still has a worthless patent, and DSS is going up, while Impact Bio is for...... Sweet Sense, Inc. We own 95.5% of the outstanding equity in Sweet Sense. page 19 Okay, DSS still has a lot of shares on the shelf that no one wants to buy. DSS, Inc. owns approximately 83.35% of the voting shares of IBO. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001834105/000164117225023809/form10-q.htm And we're allowed to vote for IBO and DSS, but unfortunately, the scammers have already stolen the absolute majority, so voting is pointless. https://www.sec.gov/Archives/edgar/data/1834105/000149315225014484/formdef14a.htm https://www.sec.gov/Archives/edgar/data/771999/000149315225018592/formdef14a.htm https://www.sec.gov/Archives/edgar/data/771999/000149315225018759/formdefr14a.htm Sat
0 · Reply
Latest News on DSS
DSS, Inc. Issues Letter to Shareholders

Feb 3, 2025, 8:50 AM EST - 9 months ago

DSS, Inc. Issues Letter to Shareholders


LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals

Jan 15, 2025, 9:35 AM EST - 10 months ago

LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals


DSS Inc. Issues Letter to Shareholders

Oct 12, 2023, 8:25 AM EDT - 2 years ago

DSS Inc. Issues Letter to Shareholders


DSS Announces Letter to Shareholders

Mar 2, 2023, 8:30 AM EST - 2 years ago

DSS Announces Letter to Shareholders


CORRECTION - DSS Announces Letter to Shareholders

Feb 28, 2022, 5:15 PM EST - 3 years ago

CORRECTION - DSS Announces Letter to Shareholders


DSS to Present at Aegis Virtual Conference

Feb 22, 2022, 5:00 PM EST - 3 years ago

DSS to Present at Aegis Virtual Conference


DSS Shareholder Alset EHome To Raise Stake To 55.52%

Jan 19, 2022, 3:57 PM EST - 4 years ago

DSS Shareholder Alset EHome To Raise Stake To 55.52%


DSS Acquires 25.1% of Alset International Limited

Jan 19, 2022, 12:13 PM EST - 4 years ago

DSS Acquires 25.1% of Alset International Limited


Impact BioMedical Announces New Bioplastics Test Results

Jan 11, 2022, 10:00 AM EST - 4 years ago

Impact BioMedical Announces New Bioplastics Test Results


DSS Enters Quantitative Investment Fund Arena

Nov 30, 2021, 7:30 AM EST - 4 years ago

DSS Enters Quantitative Investment Fund Arena


Document Security Systems Names Todd Macko Finance Chief

Aug 17, 2021, 12:46 PM EDT - 4 years ago

Document Security Systems Names Todd Macko Finance Chief


Document Security Systems Invests $1M In Vivacitas Oncology

Aug 2, 2021, 3:37 PM EDT - 4 years ago

Document Security Systems Invests $1M In Vivacitas Oncology


PSM_EmpowerTrading
PSM_EmpowerTrading Oct. 24 at 7:25 PM
⏳️ Potential swing ideas 💡 ✅️ $DSS company focuses on health information software development and systems integration, providing services and solutions used daily by thousands of clinicians and administration staff nationwide in the public and private sectors, ✅️ $CSAI announced contract to secure luxury high-rise in HOuston, announced partnerships with National Property management firm to enhance security with AI Surveillance Solutions, also, announced partnership with Crypto-mining company to cut AI operation costs using renewable energy data center in Montana, won "Project Management Solution of the year", upcoming catalyst: present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8–10, 2025, company specializing in cloud-based video surveillance, storage, analytics and monitoring solutions, offering leverage AI and computer vision to enhance security systems, Analyst price target $6, buy rating, does have mixed shelf, be mindful on next spike
1 · Reply
johannn
johannn Oct. 23 at 9:30 AM
$PRPH $DSS $AEI $IBO Aha, I see that Prophase is happy to adopt my findings and has deleted all their previous presentations because they contained quite a few inaccurate things. https://ir.prophaselabs.com/presentations
1 · Reply
johannn
johannn Oct. 23 at 6:29 AM
$PRPH $DSS $IBO https://ap.lc/pYYOb So, health insurance companies are paying $50 to $100 to those performing COVID tests, but there were "companies" charging much more for COVID tests. So, the companies that quickly made heavy investments to jump into the testing business will be running at a heavy loss. And I'm not even talking about the who tried to invoice for unperformed tests. If Ted already paid $2.5 million to take over the lease of an old testing labo. Now let's correct the esophageal cancer figures: they're only 22,070, not 22 million. So, 22,070 in the entire year 2025 (seer.cancer.gov/statfacts/h...) will have developed esophageal cancer. Whether those SUSPECTED 20 or 7 million esophageal tests were really necessary or were actually performed, I suspect someone somewhere made a mistake, and that error was copied without question. So, Ted's future profit figures for ESophageal cancer can also be consigned to the realm of fantasy. https://ap.lc/gaVJg https://ap.lc/ZTZSs
1 · Reply
Greenblacks
Greenblacks Oct. 22 at 8:24 PM
$DSS like this setup
0 · Reply
johannn
johannn Oct. 22 at 2:34 PM
$PRPH $DSS $IBO $AEI I knew it... And here again, the hyped medical journal is simply part of Elsevier publishing and isn't free, but Prophase had to pay to be included. There will be a pre-screening process to ensure it's not completely full of nonsense, but being included doesn't mean it's ready to be carved in stone/immortalized for eternity. https://www.cghjournal.org/open-access-information https://www.elsevier.com/about/policies-and-standards/pricing 🕵️‍♀️🕵️‍♀️🥷🥷👨‍🦯👨‍🦯 So, Prophase no longer has a lab/headquarters, is practically broke, and those $50 million in fantasy dollars won't amount to anything either. So, I wonder which news was actually good news if the good news was actually bought news. https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/
0 · Reply
johannn
johannn Oct. 22 at 12:28 PM
$PRPH $DSS $IBO $AEI Now, comparing the two press releases—the first one about the acquisition and the latter from today—we see the lies and discrepancies. Acquisition link: https://ir.prophaselabs.com/news-events/press-releases/detail/169/prophase-labs-acquires-rights-to-novel-esophageal-cancer Today's link: https://www.globenewswire.com/news-release/2025/10/22/3170995/0/en/ProPhase-Labs-Announces-Study-Validating-BE-Smart-Esophageal-Cancer-Test-Accepted-by-Journal-of-Clinical-Gastroenterology-and-Hepatology.html Unfortunately, Prophase will no longer have a headquarters/laboratory to perform the test in a few years. https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/ 🕵️‍♀️🕵️‍♀️🥷🥷👨‍🦯👨‍🦯
1 · Reply
johannn
johannn Oct. 22 at 12:04 PM
$PRPH $DSS $IBO https://www.stocktitan.net/news/PRPH/pro-phase-labs-announces-study-validating-be-smart-esophageal-cancer-02xgn6pt5zzp.html
0 · Reply
johannn
johannn Oct. 22 at 11:52 AM
$PRPH $DSS $IBO Laboratory/office space for rent including equipment.🕵️‍♀️🕵️‍♀️🥷🥷👨‍🦯👨‍🦯 https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/
0 · Reply
johannn
johannn Oct. 22 at 11:34 AM
$PRPH $DSS $AEI $HWH $IBO The empty box company no longer has a real office but a virtual office box virtual address is ProPhase Labs, Inc. 626 RXR Plaza, 6th Floor. Uniondale, NY 11556. (516) 989-0763. (Name, address, including zip code. The actual office used to be located at ProPhase Labs' corporate office, 711 Stewart Ave Ste 200, Garden City, New York, 11530. But now you can rent it... This office/medical space is available for lease. This property is within close proximity to Meadowbrook Parkway. https://www.loopnet.com/Listing/711-Stewart-Ave-Garden-City-NY/4004405/ So you put your money in an empty box and then set it on fire. That's how you conduct research. 🕵️‍♂️🕵️‍♂️🥷🥷🕵️‍♀️🕵️‍♀️
0 · Reply
johannn
johannn Oct. 21 at 8:34 PM
$IBO $DSS That's strange. Sweet Sense still has a worthless patent, and DSS is going up, while Impact Bio is for...... Sweet Sense, Inc. We own 95.5% of the outstanding equity in Sweet Sense. page 19 Okay, DSS still has a lot of shares on the shelf that no one wants to buy. DSS, Inc. owns approximately 83.35% of the voting shares of IBO. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001834105/000164117225023809/form10-q.htm And we're allowed to vote for IBO and DSS, but unfortunately, the scammers have already stolen the absolute majority, so voting is pointless. https://www.sec.gov/Archives/edgar/data/1834105/000149315225014484/formdef14a.htm https://www.sec.gov/Archives/edgar/data/771999/000149315225018592/formdef14a.htm https://www.sec.gov/Archives/edgar/data/771999/000149315225018759/formdefr14a.htm Sat
0 · Reply
StockFlips
StockFlips Oct. 21 at 8:16 PM
$NERV Wild and AHs going nuts too $DNUT $WOK $SHPH $DSS
2 · Reply
TheSilverBullitt
TheSilverBullitt Oct. 21 at 8:15 PM
$DSS in 1.48, out 1.74
0 · Reply
MrTicker
MrTicker Oct. 21 at 8:10 PM
$DSS on the move
0 · Reply
PatentGrants
PatentGrants Oct. 21 at 7:56 PM
$DSS DSS Inc's Sweet Sense has received a decision to grant European patent number EP3618873 titled "LOW GLYCEMIC SUGAR COMPOSITION (TO CONTROL BLOOD GLUCOSE LEVELS AND TREAT DIABETES AND RELATED CONDITIONS)". https://register.epo.org/application?number=EP18855104
0 · Reply
See2Believe
See2Believe Oct. 21 at 3:51 AM
$DSS Scam-Chan is an EVIL Man. He's a Lying Empty-Box Wheeler-Dealer using Phony Share Exchanges, and Loans which get written off, along with other Dead-End Tactics to effectively execute his eventual goal of STEALING IT ALL from Outside Shareholders (those who've PAID for their Shares). This has been going on for many years... SEC has been informed but has Turned a Blind Eye to all the Mishegoss/Craziness.
0 · Reply
johannn
johannn Oct. 17 at 9:51 PM
$PRPH $DSS $IBO $AEI $HWH Here's another link from February 25th, where we're being held up to the dregs, but nothing has been achieved. Even Stu Hollenshead, after losing all his hair, fled screaming after announcing his departure as Chief Operating Officer effective July 31, 2025. Equivir has been put on hold after fooling us for almost three years. According to the press release, the first part of the $50 million is expected... According to the company's team of litigation consultants, this initiative could net ProPhase as much as $50 million or more, with cash flow commencing mid-year. I won't list everything, but I think I've provided enough facts. https://ir.prophaselabs.com/news-events/press-releases/detail/231/prophase-labs-examines-strategic-opportunities-to-leverage Promises, promises that turn out to be lies.Learn from my mistakes and don't invest your money in these companies. There are plenty of opportunities on the stock market, but avoid these stocks.
0 · Reply
johannn
johannn Oct. 17 at 9:19 PM
$PRPH $DSS $IBO $AEI Yippie 🎇 I found a lawsuit in which Crown Medical Collections Ltd plays a role.👑 It's Chapter 11 of Bridge Diagnostic LLC, where they try to play guardian angel without any results. https://www.pacermonitor.com/view/ITYDHXY/Bridge_Diagnostic_LLC__cacbke-24-10803__0022.0.pdf https://www.inforuptcy.com/browse-filings/california-central-bankruptcy-court/8:24-bk-10803/bankruptcy-case-bridge-diagnostic-llc https://prod-i.a.dj.com/public/resources/documents/Bridge_Diagnostics.pdf Crown has been working for 1.5 years without results and keeps making empty promises. They're a good fit, Ted and Crown Medical Collections Ltd. Promises, promises, deliver results, forget it. So don't expect to see that $50 million within a few months, even if anything substantial is achieved. Whether that will happen is anyone's guess. Whether Ted can keep the empty store running without issuing additional new shares is something everyone must realize is impossible. The question remains: do you believe the man with facts, me, or the fairy tale teller, Ted?
1 · Reply
johannn
johannn Oct. 17 at 2:48 PM
$PRPH $DSS $AEI $IBO As of November 19, 2020, there were 11,604,253 shares outstanding. You can find that figure in the quarterly figures. https://www.sec.gov/Archives/edgar/data/868278/000149315220022041/form10-q.htm So, between November 19, 2020, and March 31, 2021, 15,154,253 - 11,604,253 = 3,541,000 shares were added at an average price of $10. You can calculate the rest yourself. A good example is worth following, as my great-grandfather always said. https://finance.yahoo.com/quote/PRPH/history/?period1=1603065600&period2=1617148800
1 · Reply
johannn
johannn Oct. 17 at 2:46 PM
$PRPH $DSS $AEI $IBO How Ted makes money not through entrepreneurship, but just like that other scammer Chan, by secretly printing shares or issuing convertible notes. Now, a small business doesn't have to report that it has printed shares. You have to keep in mind that the share price was many times higher than it is now. During the years when the price was high, Ted didn't report that he had printed more shares; only when the price was very low did he start reporting. As of March 26, 2019, there were 11,556,685 shares outstanding. As of March 26, 2020, there were 11,581,939 shares As of March 25, 2022, there were 15,485,900 shares As of March 24, 2023, there were 17,182,841 shares As of March 15, 2024, there were 18,045,209 shares As of March 28, 2025, there were 41,879,017 shares I'd known this for years, but I gave him a reprieve because he should have launched Equivir. Now that he hasn't and is just as much of a fraud as Chan, he can go to hell with his fake company.
1 · Reply
drjdc
drjdc Oct. 17 at 1:32 AM
$AEI $DSS $IBO $PRPH dude johannn is the smartest person on this thread and would listen to his wisdom!!
2 · Reply
KingsOnly
KingsOnly Oct. 16 at 5:21 PM
$DSS due for a pop
0 · Reply
johannn
johannn Oct. 16 at 2:22 PM
$PRPH $IBO $DSS Who is Kathleen Tibbott? Kathleen Tibbott is the President of Crown Medical Collections. Previously, Kathleen was the President of Rx Covid Test. Aha, previously, Kathleen was the President of Rx Covid Test. I find it strange that I can't find any lawsuits on the internet for Crown Medical Collection and Kathleen Tibbott as its attorney. The Crown Medical Collection website also raises many questions: no names of associated attorneys, no physical address listed on the website. If I let my imagination run wild, it seems that Ted previously purchased Covid tests from Kathleen, the President of Rx Covid Test, and together they tried to defraud health insurance companies by posting more Covid tests, sales figures, and test performances in order to defraud the insurance companies. I hope for your sake that I'm wrong, but I suspect I'll be right again. https://crownmedicalcollections.com/ https://www.zoominfo.com/p/Kathleen-Tibbott/10368464643
3 · Reply